Wikidata:Database reports/Constraint violations/P7830
Constraint violations report for LiverTox ID (Discussion, uses, items, changes, related properties): LiverTox database ID
Data time stamp: (UTC) — Items processed: 726
The report is generated based on the settings on Property:P7830#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
Data time stamp: (UTC) — Items processed: 726
The report is generated based on the settings on Property:P7830#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
"Type type of chemical entity (Q113145171), type of mixture of chemical entities (Q119892838)" violations
editViolations count: 160
- (RS)-rabeprazole (Q3515): group of stereoisomers (Q59199015)
- vitamin A (Q18225): group of chemical entities (Q55640599)
- vitamin (Q34956): group of chemical entities (Q55640599)
- Ginkgo biloba (Q43284): taxon (Q16521)
- antidepressant (Q76560): drug class (Q2585617)
- benzodiazepine drug (Q83871): pharmacological class of chemical compounds (Q55499636)
- anticholinergic (Q113259): ChEBI Ontology term (Q41014950), class of chemical entities with similar applications or functions (Q56256173)
- Trigonella foenum-graecum (Q133205): taxon (Q16521)
- vitamin E (Q141180): group of chemical entities (Q55640599)
- liver cirrhosis (Q147778): class of disease (Q112193867)
- Hoodia gordonii (Q149296): taxon (Q16521)
- vitamin D (Q175621): group of chemical entities (Q55640599)
- vitamin K (Q182338): group of chemical entities (Q55640599)
- ibuprofen (Q186969): group of stereoisomers (Q59199015)
- non-steroidal anti-inflammatory drug (Q188724): ChEBI Ontology term (Q41014950)
- omega-3 fatty acid (Q191756): structural class of chemical entities (Q47154513)
- diuretic (Q200656): ChEBI Ontology term (Q41014950)
- barbiturates (Q206348): structural class of chemical entities (Q47154513)
- antipsychotics (Q208144): ChEBI Ontology term (Q41014950)
- stimulant (Q211036):
- antiarrhythmic agent (Q241549): ChEBI Ontology term (Q41014950)
- ketamine (Q243547): group of stereoisomers (Q59199015)
- cephalosporin antibiotic (Q271021): class of chemical entities with similar applications or functions (Q56256173), structural class of chemical entities (Q47154513)
- topoisomerase inhibitor (Q281044): group or class of chemical substances (Q17339814)
- angiotensin II receptor antagonist (Q285044): drug class (Q2585617)
- Spirulina (Q285335): taxon (Q16521)
- ACE inhibitor (Q288280): drug class (Q2585617)
- histamine antagonist (Q324089):
- D-glucosamine (Q327506): group of stereoisomers (Q59199015)
- trace element (Q351792):
- Ketoconazole (Q407883): group of stereoisomers (Q59199015)
- (RS)-cyclophosphamide (Q408524): group of stereoisomers (Q59199015)
- (RS)-ketoprofen (Q409192): group of stereoisomers (Q59199015)
- H2 antagonists (Q409444):
- gonadotropins (Q409770): group or class of proteins (Q84467700)
- modafinil (Q410441): group of stereoisomers (Q59199015), nootropic (Q742487), medication (Q12140)
- boceprevir (Q410551): group of stereoisomers (Q59199015)
- carbapenem antibiotic (Q410897): group or class of chemical substances (Q17339814)
- itraconazole (Q411229): group of stereoisomers (Q59199015)
- atenolol (Q411325): group of stereoisomers (Q59199015)
- amlodipine (Q411347): group of stereoisomers (Q59199015)
- sulfonamide drug (Q411398): pharmacological class of chemical compounds (Q55499636)
- stiripentol (Q412182): group of stereoisomers (Q59199015)
- quinidine (Q412496): group of stereoisomers (Q59199015)
- carvedilol (Q412534): group of stereoisomers (Q59199015)
- bile acids (Q413288): class of chemical entities with similar source or occurrence (Q56256178)
- carbonic anhydrase inhibitor (Q414238): group or class of chemical substances (Q17339814)
- biperiden (Q414914): group of stereoisomers (Q59199015)
- fexofenadine (Q415122): group of stereoisomers (Q59199015)
- ivermectin (Q415178): mixture (Q169336), medication (Q12140), essential medicine (Q35456)
- bleomycin (Q415571): medication (Q12140), essential medicine (Q35456), mixture (Q169336)
- capreomycin (Q415909): mixture (Q169336), medication (Q12140), essential medicine (Q35456)
- colony-stimulating factor (Q416030): group or class of proteins (Q84467700)
- asenapine (Q416545): medication (Q12140), racemate (Q467717)
- pioglitazone (Q417765): group of stereoisomers (Q59199015)
- nebivolol (Q418130): group of stereoisomers (Q59199015)
- ifosfamide (Q418560): group of stereoisomers (Q59199015)
- (+-)-flurbiprofen (Q419890): group of stereoisomers (Q59199015)
- doxazosin (Q419939): group of stereoisomers (Q59199015)
- retinoid (Q420418): structural class of chemical entities (Q47154513)
- hydroxychloroquine (Q421094): group of stereoisomers (Q59199015)
- calcium channel blocker (Q421700):
- proton-pump inhibitor (Q421704): drug class (Q2585617)
- (RS)-hydroxyzine (Q421937): group of stereoisomers (Q59199015)
- fluoxetine (Q422244): group of stereoisomers (Q59199015)
- clindamycin (Q422273): group of stereoisomers (Q59199015)
- gentamicin (Q422482): mixture (Q169336), medication (Q12140), essential medicine (Q35456), extract (Q1259977)
- paliperidone (Q423292): group of stereoisomers (Q59199015)
- propranolol (Q423364): group of stereoisomers (Q59199015)
- doxylamine (Q423390): group of stereoisomers (Q59199015)
- beta2-adrenergic agonist (Q423482): class of chemical entities with similar applications or functions (Q56256173)
- triptan (Q423866):
- PDE5 inhibitor (Q424153): group or class of chemical substances (Q17339814)
- Loop diuretic (Q424280):
- (RS)-rosiglitazone (Q424771): group of stereoisomers (Q59199015)
- nadolol (Q424952): group of stereoisomers (Q59199015)
- opioid (Q427523): ChEBI Ontology term (Q41014950), drug class (Q2585617)
- green tea (Q484083): crude drug (Q735160), herbal medicinal product (Q95997873)
- antimalarial (Q521616):
- anthelmintic (Q572294): ChEBI Ontology term (Q41014950)
- Herbalife (Q572948): multi-level marketing company (Q29643579), public company (Q891723)
- antiandrogen (Q574820):
- anti-diabetic medication (Q575062): ChEBI Ontology term (Q41014950)
- antiemetic (Q575136): ChEBI Ontology term (Q41014950)
- antihypertensive drug (Q575890): ChEBI Ontology term (Q41014950)
- antifungal (Q578726): ChEBI Ontology term (Q41014950)
- antituberculous drug (Q584144):
- alkylating antineoplastic agent (Q619908):
- pralatrexate (Q637059): group of stereoisomers (Q59199015)
- autoimmune hepatitis (Q786844): designated intractable/rare disease (Q42303753), class of disease (Q112193867)
- disease-modifying antirheumatic drug (Q810254):
- beta blocker (Q816759): drug class (Q2585617)
- Petasites (Q830156): taxon (Q16521)
- Withania somnifera (Q852660): taxon (Q16521)
- enzyme replacement therapy (Q916766): replacement therapy (Q110196705)
- statin (Q954845): drug class (Q2585617), group or class of chemical entities (Q72070508)
- hypolipidemic (Q955332): ChEBI Ontology term (Q41014950)
- red yeast rice (Q1135788):
- acute liver failure (Q1192530): cause of death (Q1931388), class of disease (Q112193867)
- muscle relaxant (Q1225289):
- erythropoiesis-stimulating agent (Q1363798): essential medicine (Q35456), drug class (Q2585617)
- TNF inhibitor (Q1536078):
- metabolic dysfunction–associated steatotic liver disease (Q1546498): class of disease (Q112193867)
- gemifloxacin (Q1639595): group of stereoisomers (Q59199015)
- quinupristin/dalfopristin (Q1763990): mixture (Q169336), medication (Q12140)
- macrolide antibiotic (Q1886461): class of chemical entities with similar applications or functions (Q56256173)
- glycopeptide antibiotic (Q2293474): group or class of chemical substances (Q17339814)
- (RS)-diethylpropion (Q2356505): group of stereoisomers (Q59199015)
- amphetamines (Q2445303): structural class of chemical entities (Q47154513)
- (RS)-etodolac (Q2465218): group of stereoisomers (Q59199015)
- nucleoside analogue (Q2689559):
- dronabinol (Q2705066): international nonproprietary name (Q824258), medication (Q12140)
- low molecular weight heparin (Q2750727): class of chemical entities with similar applications or functions (Q56256173), structural class of chemical entities (Q47154513)
- general anaesthetic (Q2755101):
- antineoplastic (Q2853144): ChEBI Ontology term (Q41014950), drug class (Q2585617)
- antimigraine (Q2853292):
- aromatase inhibitor (Q3040305): class of chemical entities with similar applications or functions (Q56256173)
- saxagliptin (Q3121121): group of stereoisomers (Q59199015)
- Nodular regenerative hyperplasia (Q3144188): class of disease (Q112193867)
- phentermine/topiramate (Q3378713): medication (Q12140), chemical substance (Q79529), mixture (Q169336)
- antiparkinson (Q3579672): medication (Q12140)
- antiasthmatic (Q3618576): drug class (Q2585617)
- defibrotide (Q3704725): medication (Q12140), biopharmaceutical (Q679692), mixture (Q169336)
- echinocandin (Q3718510): group of chemical entities (Q55640599)
- Vanishing bile duct syndrome (Q3961650):
- antineoplastic antibiotics (Q4381760):
- antithrombotic (Q4775337):
- fulvestrant (Q5508491): group of stereoisomers (Q59199015)
- gabapentin enacarbil (Q5515257): group of stereoisomers (Q59199015)
- green tea extract (Q5603593): extract (Q1259977)
- Purine analogue (Q6593447):
- chelating agent (Q11872304): class of chemical entities with similar applications or functions (Q56256173)
- ergot alkaloids (Q12748271): class of chemical entities with similar source or occurrence (Q56256178)
- antigout agent (Q17173047): medication (Q12140)
- liver neoplasm (Q18558073): class of disease (Q112193867)
- ginseng (Q20817212): medicinal plant (Q188840), medication (Q12140), food ingredient (Q25403900)
- interferon-alpha (Q20817235): medication (Q12140), biopharmaceutical (Q679692)
- sebelipase alfa (Q21789862): medication (Q12140), enzyme (Q8047)
- artesunate/mefloquine (Q28163619): medication (Q12140), essential medicine (Q35456), mixture (Q169336)
- emapalumab (Q28209889): medication (Q12140), monoclonal antibody (Q422248)
- fluoroquinolone (Q28801726): pharmacological class of chemical compounds (Q55499636)
- fremanezumab (Q39048381): medication (Q12140), monoclonal antibody (Q422248)
- antiviral agent (Q40207875): ChEBI Ontology term (Q41014950)
- anti-ulcer drug (Q41602594): ChEBI Ontology term (Q41014950)
- aminoglycoside antibiotic (Q45355603): class of chemical entities with similar applications or functions (Q56256173)
- HIV protease inhibitors (Q50315992): class of chemical entities with similar applications or functions (Q56256173)
- anti-infective agent (Q50377176): group or class of chemical substances (Q17339814)
- hypnotics and sedatives (Q50377192):
- gastrointestinal agent (Q50377202):
- fertility agents (Q50429990):
- adrenergic alpha-1 receptor antagonists (Q50430371):
- Serotonin 5-HT4 Receptor Agonists (Q50430392):
- cemiplimab (Q55606818): medication (Q12140)
- ravulizumab (Q55641547): monoclonal antibody (Q422248), medication (Q12140)
- tagraxofusp-erzs (Q60666292): medication (Q12140), fusion protein (Q425158)
- bilberry (Q60708120): organisms known by a particular common name (Q55983715), crude drug (Q735160), herbal medicinal product (Q95997873)
- chronic hepatitis (Q62019625): disease (Q12136)
- purple coneflower root (Q72470595): extract (Q1259977), crude drug (Q735160), herbal medicinal product (Q95997873), mixture (Q169336)
- kava kava (Q96097703): crude drug (Q735160), herbal medicinal product (Q95997873)
- Asparaginase (Q105296036): medication (Q12140), biopharmaceutical (Q679692), essential medicine (Q35456), asparaginase (Q421534)
Types statistics
edit
"Single value" violations
editViolations count: 2
- tetracycline (Q193045): Tetracyclines, TetracyclineAndOxyte
- stimulant (Q211036): CytotoxicAntibiotics, CNSStimulants
"Unique value" violations
editViolations count: 2
- CytotoxicAntibiotics: stimulant (Q211036), antineoplastic antibiotics (Q4381760)
- GreenTea: green tea (Q484083), green tea extract (Q5603593)
"Format" violations
editViolations count: 0
"Entity types" violations
editViolations count: 0
"Scope" violations
editViolations count: 0